ZARLAQUIX Trademark

Trademark Overview

On Friday, October 26, 2018, a trademark application was filed for ZARLAQUIX with the United States Patent and Trademark Office. The USPTO has given the ZARLAQUIX trademark a serial number of 88171191. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 20, 2022. This trademark is owned by JOHNSON & JOHNSON. The ZARLAQUIX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of oncological diseases and disorders
zarlaquix

General Information

Serial Number88171191
Word MarkZARLAQUIX
Filing DateFriday, October 26, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Tuesday, June 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 20, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 9, 2021SOU EXTENSION 5 GRANTED
Thursday, November 4, 2021SOU EXTENSION 5 FILED
Tuesday, November 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 4, 2021TEAS EXTENSION RECEIVED
Wednesday, April 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 12, 2021SOU EXTENSION 4 GRANTED
Monday, April 12, 2021SOU EXTENSION 4 FILED
Monday, April 12, 2021TEAS EXTENSION RECEIVED
Wednesday, October 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 19, 2020SOU EXTENSION 3 GRANTED
Monday, October 19, 2020SOU EXTENSION 3 FILED
Monday, October 19, 2020TEAS EXTENSION RECEIVED
Thursday, April 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 28, 2020SOU EXTENSION 2 GRANTED
Tuesday, April 28, 2020SOU EXTENSION 2 FILED
Tuesday, April 28, 2020TEAS EXTENSION RECEIVED
Thursday, October 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2019SOU EXTENSION 1 GRANTED
Tuesday, October 29, 2019SOU EXTENSION 1 FILED
Tuesday, October 29, 2019TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 1, 2019ASSIGNED TO EXAMINER
Friday, November 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 30, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

zarlaquix diseases disorders oncological treatment preparations pharmaceutical